Management | Medibuddy
27th May 2025

Management

The management of Cushing’s syndrome depends on the aetiology. Management in each case is summarised below:

Aetiology Management Comments
Cushing’s disease (ACTH-secreting pituitary adenoma) Transsphenoidal pituitary adenomectomy Performed endoscopically or microscopically.
Somatostatin analogues e.g. pasireotide, steroidogenesis inhibitors e.g. osilodrostat, glucocorticoid receptor antagonists e.g. mifepristone These are used to address short-term severe hypercortisolism whilst awaiting definitive treatment, or if the patient is not fit for surgery.
Hormonal replacement Due to pituitary resection, replacement of thyroxine, gonadal hormones, somatropin and desmopressin may be needed.
Pituitary radiotherapy Indicated if high cortisol persists post-tumour resection.
Ectopic ACTH Surgical resection of tumour/metastases Resection of ectopic tumours responsible for ACTH (or CRH) production.
Steroidogenesis inhibitors, glucocorticoid receptor antagonists As above.
Chemotherapy and radiotherapy As above.
Adrenal carcinoma or adenoma Laparoscopic adrenalectomy or tumour resection Unilateral resection is often curative without subsequent adrenal insufficiency.
Steroidogenesis inhibitors, glucocorticoid receptor antagonists As above.
Chemotherapy and radiotherapy Adrenal carcinoma will often require this, as it often will have progressed at time of diagnosis.
Bilateral adrenal hyperplasia or adenoma Bilateral adrenalectomy Resection is often curative without subsequent adrenal insufficiency. In some cases mineralocorticoid and corticosteroid replacement may be indicated.
Steroidogenesis inhibitors, glucocorticoid receptor antagonists As above.
Exogenous glucocorticoids Gradual withdrawal of glucocorticoids Aiming to discontinue or reduce maintenance dose.

Table 2: Management of Cushing’s syndrome dependent on aetiology.

Mobile app screenshots

Take your subscriptions with you

Our mobile app allows you to access your interview and exam question banks wherever you are.